
    
      Recruit up to 70 subjects whom participated in protocol TPX-100-1. The opposing knee that was
      treated will be getting 200mg in 4 weekly injections. The knee that was treated in TPX-100-1
      will get randomized to either 200mg dose or a placebo lookalike. The investigators will
      follow these subjects for 6 months. Two MRIs of bi-lateral knees will be assessed. Also
      collection of ADA samples at 4 time points through the 6 month period.
    
  